Some patients may benefit from very low-calorie diets (800 kcal/day) under medical supervision, particularly those with type 2 diabetes or significant obesity-related complications, as outlined in NICE CG189
Likewise, those with a BMI 27 kg/m who are considered overweight may also be eligible if they have at least one weight-related comorbid condition, such as high blood pressure, type 2 diabetes, or high cholesterol
While the future of weight management currently looks bleak, there is opportunity for brands to develop more effective and targeted products catering to both GLP-1 users and natural ingredient purists
When integrated into a standardized research protocol, FOXO4-Dri 10mg provides a consistent baseline for observing physiological changes, enzymatic interactions, and gene expression profiles
Clinical trials of GLP-1 drugs have found they can lower inflammation, decrease the risk of cardiovascular and kidney disease and may help cut cravings for alcohol and tobacco